2014
DOI: 10.1016/j.biopha.2014.05.003
|View full text |Cite
|
Sign up to set email alerts
|

NLK, a novel target of miR-199a-3p, functions as a tumor suppressor in colorectal cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
26
0

Year Published

2015
2015
2020
2020

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 33 publications
(27 citation statements)
references
References 27 publications
1
26
0
Order By: Relevance
“…The only unconfirmed miRNA was hsa-mir-199a. As a matter of fact, evidences have demonstrated that hsa-mir-199a plays a critical role in the cell biological behaviors of colorectal cancer through its target genes[59]. Our prediction results were consistent with existing findings and provided computational evidence for its association with CN.…”
Section: Resultssupporting
confidence: 88%
“…The only unconfirmed miRNA was hsa-mir-199a. As a matter of fact, evidences have demonstrated that hsa-mir-199a plays a critical role in the cell biological behaviors of colorectal cancer through its target genes[59]. Our prediction results were consistent with existing findings and provided computational evidence for its association with CN.…”
Section: Resultssupporting
confidence: 88%
“…For instance, in human colon cancer overexpression of NLK in DLD-1 human colon cancer cell line could induce apoptosis and inhibit cell growth [9]. Moreover, NLK expression was significantly downregulated in colorectal cancer (CRC) tumor tissues than adjacent nontumor tissues [16]. Overexpression of NLK could induce apoptosis and inhibit androgen receptor-mediated transcription in human prostate cancer cells [17].…”
Section: Discussionmentioning
confidence: 99%
“…Ectopic overexpression of miR-101 represses cell growth and proliferation and imitates NLK knockdown effect on HCC cells [28]. NLK is confirmed as a target of miR-199a-3p, and downregulated NLK amplifies proliferation, migration, and invasion and prevents apoptosis in CRC cells [18]. miR-197 can promote Taxol resistance, cell proliferation, and invasion of ovarian cancer cells by regulating NLK expression [29].…”
Section: Upstream Regulators Of Nlk In Cancersmentioning
confidence: 96%
“…A significant decrease of NLK mRNA level evaluated by quantitative real-time polymerase chain reaction (qRT-PCR) is observed in colorectal cancer (CRC) patients with a median change by about 0.56-fold compared with the non-tumor tissues, and the low NLK expression group has a significantly shorter overall survival rate than that of the high NLK expression group [18]. However, conflicting findings are reported by Chen et al recently.…”
Section: Altered Expression Of Nlk In Cancersmentioning
confidence: 99%